[시장보고서]세계의 단위 용량 포장 시장 : 형태별, 소재 유형별, 제품 유형별, 최종 이용 산업별, 지역별 예측(-2029년)

세계의 단위 용량 포장 시장 : 형태별, 소재 유형별, 제품 유형별, 최종 이용 산업별, 지역별 예측(-2029년)

Unit Dose Packaging Market by Form (Liquid, Solid, Powder, Gel), Material Type (Plastic, Glass, Paper, Aluminium), Product Type, End-use industry (Pharmaceuticals, Cosmetic & Personal Care, Nutraceuticals), and Region - Global Forecast to 2029

상품코드 : 1527781 해당 상품은 즉시 배송 가능합니다

리서치사 : MarketsandMarkets

발행일 : 2024년 08월

페이지 정보 : 영문 230 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,950

￦ 7,344,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650

￦ 9,866,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 12,092,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,837,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

단위 용량 포장 시장 규모는 2024년 291억 달러에서 2029년 438억 달러로 성장할 것으로 예측되며, 예측 기간 중 복합 연간 성장률(CAGR)은 8.5%가 될 전망입니다.

약물의 안전성, 정확성 및 편의성을 보장하는 데 중요한 이점이 있기 때문에 블리스터 포장에 대한 수요가 증가함에 따라 단위 용량 포장 시장의 성장이 크게 촉진되고 있습니다. 플라스틱 및 호일 구획에 개별 투약량을 포함하는 물집 포장은 의약품을 습기와 빛으로부터 보호하고 효능을 유지할 수 있기 때문에 제약 업계에서 널리 사용됩니다. 피임용 알약과 시중에서 판매되는 진통제와 같은 의약품은 종종 블리스터 팩에 포장되어 환자가 복용량을 쉽게 파악하고 복약 일정을 보호하는 데 도움이 됩니다. 이 방법은 각 복용량을 명확하게 나누고 라벨링함으로써 환자의 컴플라이언스를 향상시킬 뿐만 아니라 투약 실수도 줄일 수 있습니다. 물집 팩의 편의성은 바쁜 라이프 스타일을 보내는 사람들에게 이상적이며 인기가 더욱 높아지고 있습니다. 헬스케어 부문은 환자의 안전성과 복약 준수를 중시하고 블리스터 패키징의 실용적인 이점과 함께 다양한 산업에의 도입을 계속 추진하고 있습니다.

조사 범위
조사 대상년도	2022년-2029년
기준년	2023
예측 기간	2024년-2029년
검토 단위	금액(100만 달러)
부문	형태별, 소재 유형별, 제품 유형별, 최종 이용 산업별, 지역별
대상 지역	북미, 아시아태평양, 유럽, 남미, 중동 및 아프리카

고체 단위 용량 포장은 30-35%로 추정된 상당한 점유율을 차지합니다. 이 포장 형태는 정제 및 캡슐 블리스터 팩이 일반적인 의약품에서 널리 사용됩니다. 이부프로펜, 항히스타민제, 멀티비타민제 등의 제품은 정확한 복용과 환경 요인으로부터의 보호를 보장하기 위해 이러한 방식으로 포장되는 경우가 많습니다. 영양 보조 식품 분야에서는 비타민과 오메가 3 캡슐과 같은 영양 보조 식품에 고체 단위 용량 포장이 채택되어 편리하고 정확한 복용량을 제공합니다. 화장품은 또한 스킨 케어 트리트먼트나 페이스 마스크가 들어간 일회용 캡슐 등에 고형 단위 용량 포장을 사용하고 있습니다. 고체 단위 용량 포장의 성장은 제약 업계의 광범위한 용도에 의해 크게 견인되고 있습니다.

플라스틱은 모노머를 다양한 구성으로 연결하여 만들어지는 합성 재료로 유연성, 내구성, 열화에 대한 내성 등의 독자적인 특성을 갖추고 있습니다. 단위 용량 포장 산업에서 폴리에틸렌(PE), 폴리프로필렌(PP), 폴리염화비닐(PVC)과 같은 플라스틱은 습기, 빛, 가스 및 오염물질에 대한 효과적인 장벽으로 평가되고 있습니다. 이 물질은 정확한 투여 능력, 변조 방지 씰 및 간편한 개방 특성으로 건강 관리 및 의약품에서 매우 중요하며 안전하고 사용자 친화적 인 약물 전달을 보장합니다. 플라스틱 포장은 비용 효율적이며 폐기물을 줄이고 엄격한 무균 및 규제 기준을 충족하므로 의약품의 안전과 효과를 유지할 수 있습니다. 유리나 알루미늄에 비해, 플라스틱은 경량으로 내충격성이 뛰어나 설계의 유연성이 있기 때문에 다양한 용도에 맞춘 특수한 형상이나 사이즈에 대응할 수 있습니다.

물집 팩은 열 성형 플라스틱의 공동과 유연한 상단으로 구성되어 내용물을 습기, 가스, 빛, 물리적 손상으로부터 보호하여 무결성을 유지하고 보존 기간을 연장하도록 설계되었습니다. 의약품, 비타민제, 보충제 및 기타 제품을 한 번씩 안전하게 보관할 수 있습니다. 지속가능성에 대한 우려에 대응하기 위해 최신 블리스터 팩은 친환경 소재와 효율적인 설계를 채택하여 의약품, 영양보조식품, 의료기기 시장 요구를 충족하면서 환경에 미치는 영향을 최소화 로 억제하고 있습니다. 블리스터 팩은 제품의 보호를 강화하고, 정확한 투여를 보장하며, 안전성을 높임으로써 포장의 효율화에 기여하고 있습니다.

본 보고서에서는 세계 단위용량 포장 시장에 대해 조사했으며, 형태별, 소재 유형별, 제품 유형별, 최종 이용 산업별, 지역별 동향 및 시장 진출기업 프로파일 등을 정리했습니다.

Porter's Five Forces 분석
밸류체인 분석
무역 분석
생성형 AI가 단위 용량 포장에 미치는 영향
거시경제지표
기술 분석
관세 및 규제 상황
사례 연구 분석
고객사업에 영향을 주는 동향과 혼란
주된 회의와 이벤트(2024년-2025년)
주요 이해관계자와 구매 기준
생태계 분석
특허 분석
가격 분석

제7장 단위 용량 포장 시장(형태별)

소개
액체
고체
분말
겔

제8장 단위 용량 포장 시장(소재 유형별)

소개
플라스틱
유리
종이?판지
알루미늄
기타

제9장 단위 용량 포장 시장(제품 유형별)

소개
블리스터 팩
사쉐 스트립 팩
앰풀 바이알
기타

제10장 단위 용량 포장 시장(최종 이용 산업별)

소개
의약품
화장품?퍼스널케어
영양보조식품
기타

제11장 단위 용량 포장 시장(지역별)

소개
아시아태평양
유럽
북미
남미
중동 및 아프리카

제12장 경쟁 구도

개요
주요 진입기업의 전략/비책
수익 분석
시장 점유율 분석
기업이치평가와 재무지표
제품/브랜드 비교 분석
기업평가 매트릭스: 주요 진입기업(2023년)
기업평가 매트릭스: 스타트업/중소기업(2023년)
경쟁 시나리오와 동향

제13장 기업 프로파일

주요 진출기업
- PFIZER INC.
- AMCOR PLC
- CORNING INCORPORATED
- WEST PHARMACEUTICAL SERVICES
- STEVANATO GROUP
- GERRESHEIMER AG
- SCHOTT
- NIPRO
- CONSTANTIA FLEXIBLES
- KLOCKNER PENTAPLAST
기타 기업
- SONIC PACKAGING INDUSTRIES INC.
- SHARP SERVICES, LLC
- TEKNI-PLEX, INC.
- THERMO-PAK CO. INC.
- APHENA PHARMA SOLUTIONS
- PACIFIC VIAL MANUFACTURING INC.
- HEALTH CARE LOGISTICS, INC.
- ULTRA SEAL CORPORATION
- SAFECORE HEALTH
- UNIT PACK
- JONES HEALTHCARE GROUP
- ROPACK INC.
- RX SYSTEMS, INC.
- JAMES ALEXANDER CORPORATION
- PHARMACY AUTOMATION SUPPLIES

제14장 인접 시장과 관련 시장

제15장 부록

BJH

영문 목차

영문목차

The unit dose packaging market is projected to grow from USD 29.1 Billion in 2024 to USD 43.8 Billion by 2029, at a CAGR of 8.5% during the forecast period. The rising demand for blister packaging is significantly driving the growth of the unit dose packaging market due to its key advantages in ensuring medication safety, accuracy, and convenience. Blister packaging, which encloses individual doses in plastic and foil compartments, is widely used in the pharmaceutical industry for its ability to protect medications from moisture and light, preserving their potency. Medications such as birth control pills and over-the-counter pain relievers are often packaged in blister packs, which help patients easily track doses and adhere to their medication schedules. This method not only improves patient compliance by clearly separating and labeling each dose but also reduces medication errors. The convenience of blister packaging makes it ideal for individuals with busy lifestyles, further boosting its popularity. The healthcare sector's emphasis on patient safety and adherence, along with the practical benefits of blister packaging, continues to drive its adoption across various industries.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD Million)
Segments	Form, Material Type, Product Type, End-Use Industry, and Region
Regions covered	North America, Asia Pacific, Europe, South America, and Middle East & Africa

"By Form, solid is the second largest market share for unit dose packaging during forecast period."

Solid unit dose packaging accounts for a substantial share, estimated at 30-35%. This packaging format is widely used in pharmaceuticals, where blister packs for tablets and capsules are common. Products such as ibuprofen, antihistamines, and multivitamins are frequently packaged in this way to ensure precise dosing and protection from environmental factors. In the nutraceutical sector, solid unit dose packaging is employed for vitamins and dietary supplements like Omega-3 capsules, providing convenience and accurate dosing. Cosmetics also use solid unit dose formats for items such as single-use capsules containing skincare treatments and face masks. The growth of solid unit dose packaging is largely driven by its extensive application in the pharmaceutical industry.

"By Material Type, plastic account for largest market share for unit dose packaging during forecast period."

Plastic, a synthetic material made by linking monomers in various configurations, offers unique properties like flexibility, durability, and resistance to degradation. In the unit dose packaging industry, plastics such as polyethylene (PE), polypropylene (PP), and polyvinyl chloride (PVC) are valued for their effective barriers against moisture, light, gases, and contaminants. These materials are crucial in healthcare and pharmaceuticals due to their precise dosing capabilities, tamper-evident seals, and easy-open features, ensuring secure and user-friendly medication delivery. Plastic packaging is cost-effective, reducing waste and meeting stringent sterility and regulatory standards, thus maintaining medication safety and efficacy. Compared to glass and aluminum, plastics are preferred for their lightweight nature, impact resistance, and design flexibility, accommodating specialized forms and sizes for various applications.

"By Product Type, blister pack account for largest share during forecast period."

Blister packs consist of a thermoformed plastic cavity and a flexible top, designed to protect contents from moisture, gases, light, and physical damage, thereby preserving their integrity and extending shelf life. They securely house individual doses of medications, vitamins, supplements, and other products. To address sustainability concerns, modern blister packs use eco-friendly materials and efficient designs to minimize environmental impact while meeting market needs in pharmaceuticals, nutraceuticals, and medical devices. Blister packs contribute to packaging efficiency by enhancing product protection, ensuring precise dosing, and increasing safety. Leading companies such as Amcor plc, Constantia Flexibles, and West Pharmaceutical Services are incorporating smart technologies like RFID (Radio Frequency Identification) and NFC (Near Field Communication) into blister packs to improve tracking, authentication, and real-time monitoring. Additionally, Klockner Pentaplast offers advanced films with high clarity, autoclavable laminate, and robust barriers against moisture and package leaching. These films are ideal for hot-fill liquids and new dosage forms, providing customizable moisture protection, high heat stability, quick release, and excellent odor and flavor retention.

"By End-Use Industry, Pharmaceutical End-use Industry Segment Accounted For largest share during forecast period."

Unit dose packaging is crucial in the pharmaceutical industry for distributing precise doses of medications, vitamins, oral liquids, and injectables. It ensures that each dose is securely contained in a sealed package, such as vials, ampoules, or blister packs. Technologies like Blow-Fill-Seal (BFS) streamline the sterile packaging process, minimizing contamination risks and enhancing product safety. The trend towards prefilled syringes and auto-injectors provides accurate dosing and improved patient compliance with added safety features. Innovations in sensors and indicators monitor environmental conditions to maintain medication efficacy. The shift towards sustainable materials and optimized packaging sizes highlights the industry's commitment to reducing environmental impact while enhancing patient safety and dosing accuracy.

"North America is accounted larget market for Unit dose packaging in 2023."

The North America region is accounted larget in the unit dose packaging market. This growth encompasses countries like US, Canada, and Mexico.

The unit dose packaging market in North America is being propelled by various factors. In North America, the pharmaceutical industry heavily relies on unit dose packaging for its precision, patient compliance, and protection against contamination and tampering. This demand is driven by a focus on patient-centric solutions, the need for accurate dosing to reduce errors, and the convenience of use. The aging population and high prevalence of chronic diseases further boost the need for pharmaceuticals and healthcare services. According to pharma association, in 2023, the industry invested around USD 90 billion in R&D, reflecting its growth. Stringent regulations by the FDA and Health Canada ensure compliance with safety and quality standards, influencing packaging choices. Despite significant growth, challenges such as increased competition, innovation, and environmental regulations pose constraints to the market.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the unit dose packaging market.

By Company Type: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
By Designation: C Level: 35%, Director Level: 30%, and Others: 35%
By Region: North America: 25%, Europe: 20%, APAC: 45%, Middle East & Africa: 5%, and South America: 5%

Companies Covered: The global unit dose packaging market comprises major manufacturers, such as Pfizer Inc. (US), Amcor Plc (Switzerland), Corning Incorporated (US), West Pharmaceutical Services (US), Stevanato Group (Italy), Gerresheimer AG (Germany), SCHOTT (Germany), Nipro (Japan), Constantia Flexibles (Austria), and Klockner Pentaplast (UK), among others.

Research Coverage

The market study covers the unit dose packaging market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on form, material type, product type, end-use industry, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the unit dose packaging market.

Key Benefits of Buying the Report

The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall unit dose packaging market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (Thriving Pharmaceutical Sector and surge in healthcare expenditure, Rising demand for blister packaging, and Consumer preference for convenience and portability driving demand for unit dose packaging), restraints (The setup and maintenance of unit dose packaging machines and Environmental concerns), opportunities (Increasing demand for primary pharmaceutical packaging and Market expansion in nutraceuticals and cosmetics) and challenges (Technological challenges in the unit dose packaging market and High initial investment).
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the unit dose packaging market
Market Development: Comprehensive information about lucrative markets - the report analyses the unit dose packaging market across varied regions

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the unit dose packaging market

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Pfizer Inc. (US), Amcor Plc (Switzerland), Corning Incorporated (US), West Pharmaceutical Services (US), Stevanato Group (Italy), Gerresheimer AG (Germany), SCHOTT (Germany), Nipro (Japan), Constantia Flexibles (Austria), and Klockner Pentaplast (UK), among others in the unit dose packaging market. The report also helps stakeholders understand the pulse of the unit dose packaging market and provides them with information on key market drivers, restraints, challenges, and opportunities.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
- 1.3.1 UNIT DOSE PACKAGING MARKET SEGMENTATION
- 1.3.2 YEARS CONSIDERED
- 1.3.3 CURRENCY CONSIDERED
- 1.3.4 UNITS CONSIDERED
1.4 LIMITATIONS
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Key data from primary sources
  - 2.1.2.2 Key primary participants
  - 2.1.2.3 Key industry insights
  - 2.1.2.4 Breakdown of interviews with experts
2.2 MARKET SIZE ESTIMATION
- 2.2.1 BOTTOM-UP APPROACH
- 2.2.2 TOP-DOWN APPROACH
2.3 FORECAST NUMBER CALCULATION
2.4 DATA TRIANGULATION
2.5 FACTOR ANALYSIS
2.6 ASSUMPTIONS
2.7 RESEARCH LIMITATIONS AND RISKS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN UNIT DOSE PACKAGING MARKET
4.2 NORTH AMERICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY AND COUNTRY
4.3 NORTH AMERICA UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE
4.4 NORTH AMERICA UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY
4.5 UNIT DOSE PACKAGING MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Thriving pharmaceutical sector and surge in healthcare expenditure
  - 5.2.1.2 Rising demand for blister packaging
  - 5.2.1.3 Consumer preference for convenience and portability
- 5.2.2 RESTRAINTS
  - 5.2.2.1 Substantial capital investment required for setup and maintenance of unit dose packaging machines
  - 5.2.2.2 Environmental concerns
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Increasing demand for primary pharmaceutical packaging
  - 5.2.3.2 Market expansion in nutraceuticals and cosmetics
- 5.2.4 CHALLENGES
  - 5.2.4.1 Technological challenges
  - 5.2.4.2 High initial investment

6 INDUSTRY TRENDS

6.1 PORTER'S FIVE FORCES ANALYSIS
- 6.1.1 THREAT OF NEW ENTRANTS
- 6.1.2 THREAT OF SUBSTITUTES
- 6.1.3 BARGAINING POWER OF SUPPLIERS
- 6.1.4 BARGAINING POWER OF BUYERS
- 6.1.5 INTENSITY OF COMPETITIVE RIVALRY
6.2 VALUE CHAIN ANALYSIS
6.3 TRADE ANALYSIS
- 6.3.1 EXPORT SCENARIO
- 6.3.2 IMPORT SCENARIO
6.4 IMPACT OF GEN AI ON UNIT DOSE PACKAGING
- 6.4.1 INTEGRATING AI IN UNIT DOSE PACKAGING
- 6.4.2 BEST PRACTICES TO LEVERAGE AI FOR UNIT DOSE PACKAGING MARKET
- 6.4.3 USE CASES OF GENERATIVE AI IN UNIT DOSE PACKAGING MARKET
  - 6.4.3.1 Future of generative AI in unit dose packaging market
6.5 MACROECONOMIC INDICATORS
- 6.5.1 GLOBAL GDP OUTLOOK
6.6 TECHNOLOGY ANALYSIS
- 6.6.1 KEY TECHNOLOGIES
  - 6.6.1.1 Blister packaging
  - 6.6.1.2 Strip packaging
  - 6.6.1.3 Blow-Fill-Seal
- 6.6.2 COMPLEMENTARY TECHNOLOGIES
  - 6.6.2.1 Smart packaging
  - 6.6.2.2 Barrier and coating
6.7 TARIFF AND REGULATORY LANDSCAPE
- 6.7.1 TARIFF RELATED TO UNIT DOSE PACKAGING MARKET
- 6.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.8 CASE STUDY ANALYSIS
6.9 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
6.10 KEY CONFERENCES & EVENTS IN 2024-2025
6.11 KEY STAKEHOLDERS AND BUYING CRITERIA
- 6.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 6.11.2 BUYING CRITERIA
6.12 ECOSYSTEM ANALYSIS
6.13 PATENT ANALYSIS
- 6.13.1 INTRODUCTION
- 6.13.2 METHODOLOGY
6.14 PRICING ANALYSIS
- 6.14.1 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING, BY REGION
- 6.14.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MATERIAL TYPE
- 6.14.3 INVESTMENT AND FUNDING SCENARIO

7 UNIT DOSE PACKAGING MARKET, BY FORM

7.1 INTRODUCTION
7.2 LIQUID
7.3 SOLID
7.4 POWDER
7.5 GEL

8 UNIT DOSE PACKAGING MARKET, BY MATERIAL TYPE

8.1 INTRODUCTION
8.2 PLASTIC
- 8.2.1 POLYVINYL CHLORIDE
- 8.2.2 POLYETHYLENE
- 8.2.3 POLYPROPYLENE
- 8.2.4 POLYETHYLENE TEREPHTHALATE
- 8.2.5 OTHER PLASTIC FILMS
8.3 GLASS
8.4 PAPER & PAPERBOARD
8.5 ALUMINUM
8.6 OTHER MATERIAL TYPES

9 UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE

9.1 INTRODUCTION
9.2 BLISTER PACKS
- 9.2.1 ENSURE DRUG DOSING ACCURACY AND INCREASED SAFETY
9.3 SACHETS & STRIP PACKS
- 9.3.1 MAINTAIN PRODUCT FRESHNESS AND QUALITY
9.4 AMPOULES & VIALS
- 9.4.1 USED FOR STORING AND DISPENSING LIQUID PHARMACEUTICALS
9.5 OTHER PRODUCT TYPES

10 UNIT DOSE PACKAGING, BY END-USE INDUSTRY

10.1 INTRODUCTION
10.2 PHARMACEUTICALS
- 10.2.1 INCREASED DEMAND FOR PREFILLED SYRINGES AND AUTO-INJECTORS
10.3 COSMETICS & PERSONAL CARE
- 10.3.1 EXTENDING SHELF LIFE OF BEAUTY PRODUCTS
10.4 NUTRACEUTICALS
- 10.4.1 ADMINISTRATION OF PRECISE DOSAGE AND CONSUMER COMPLIANCE
10.5 OTHER END-USE INDUSTRIES

11 UNIT DOSE PACKAGING MARKET, BY REGION

11.1 INTRODUCTION
11.2 ASIA PACIFIC
- 11.2.1 CHINA
  - 11.2.1.1 Rising investments in biologics and biosimilar drug research to drive market
- 11.2.2 INDIA
  - 11.2.2.1 Large domestic consumption and export of generic drugs to drive market
- 11.2.3 JAPAN
  - 11.2.3.1 Surge in aging population to drive demand for medications
- 11.2.4 SOUTH KOREA
  - 11.2.4.1 Growth of cosmetic & personal care industries to drive market
- 11.2.5 REST OF ASIA PACIFIC
11.3 EUROPE
- 11.3.1 GERMANY
  - 11.3.1.1 Advanced healthcare infrastructure and emphasis on patient-centric care to drive market
- 11.3.2 FRANCE
  - 11.3.2.1 Surge in demand for generic drugs to drive market
- 11.3.3 ITALY
  - 11.3.3.1 Growing exports of pharmaceutical products to boost market
- 11.3.4 UK
  - 11.3.4.1 Innovations in drug manufacturing to drive market
- 11.3.5 SPAIN
  - 11.3.5.1 Growth of cosmetic & personal care industry to drive market
- 11.3.6 REST OF EUROPE
11.4 NORTH AMERICA
- 11.4.1 US
  - 11.4.1.1 Increasing demand for RFID integration and smart packaging to drive market
- 11.4.2 CANADA
  - 11.4.2.1 Rising demand for precise packaging to drive market
- 11.4.3 MEXICO
  - 11.4.3.1 Technological advancements and packaging innovations to boost market
11.5 SOUTH AMERICA
- 11.5.1 BRAZIL
  - 11.5.1.1 Increased healthcare awareness and substantial investment to drive market
- 11.5.2 ARGENTINA
  - 11.5.2.1 Innovations in packaging to drive market
- 11.5.3 REST OF SOUTH AMERICA
11.6 MIDDLE EAST & AFRICA
- 11.6.1 GCC COUNTRIES
  - 11.6.1.1 Saudi Arabia
    - 11.6.1.1.1 Saudi Vision 2030 to boost demand for advanced medical packaging solutions
  - 11.6.1.2 UAE
    - 11.6.1.2.1 Increasing demand for dietary supplements and functional foods to drive market
  - 11.6.1.3 Rest of GCC countries
- 11.6.2 SOUTH AFRICA
  - 11.6.2.1 Government initiatives upholding safety and efficacy standards to boost market
- 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.3 REVENUE ANALYSIS
12.4 MARKET SHARE ANALYSIS
12.5 COMPANY VALUATION AND FINANCIAL METRICS
12.6 PRODUCT/BRAND COMPARISON ANALYSIS
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 12.7.1 STARS
- 12.7.2 EMERGING LEADERS
- 12.7.3 PERVASIVE PLAYERS
- 12.7.4 PARTICIPANTS
- 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 12.7.5.1 Company footprint
  - 12.7.5.2 Form footprint
  - 12.7.5.3 Material type footprint
  - 12.7.5.4 Product type footprint
  - 12.7.5.5 End-use industry footprint
  - 12.7.5.6 Region footprint
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 12.8.1 PROGRESSIVE COMPANIES
- 12.8.2 RESPONSIVE COMPANIES
- 12.8.3 DYNAMIC COMPANIES
- 12.8.4 STARTING BLOCKS
- 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.9 COMPETITIVE SCENARIO AND TRENDS
- 12.9.1 PRODUCT LAUNCHES
- 12.9.2 DEALS
- 12.9.3 EXPANSIONS

13 COMPANY PROFILES

13.1 KEY PLAYERS
- 13.1.1 PFIZER INC.
  - 13.1.1.1 Business overview
  - 13.1.1.2 Products/Solutions/Services offered
  - 13.1.1.3 Recent developments
    - 13.1.1.3.1 Product launches
    - 13.1.1.3.2 Deals
  - 13.1.1.4 MnM view
    - 13.1.1.4.1 Right to win
    - 13.1.1.4.2 Strategic choices
    - 13.1.1.4.3 Weaknesses & competitive threats
- 13.1.2 AMCOR PLC
  - 13.1.2.1 Business overview
  - 13.1.2.2 Products/Solutions/Services offered
  - 13.1.2.3 Recent developments
    - 13.1.2.3.1 Product launches
    - 13.1.2.3.2 Expansion
  - 13.1.2.4 MnM view
    - 13.1.2.4.1 Right to win
    - 13.1.2.4.2 Strategic choices
    - 13.1.2.4.3 Weaknesses & competitive threats
- 13.1.3 CORNING INCORPORATED
  - 13.1.3.1 Business overview
  - 13.1.3.2 Products/Solutions/Services offered
  - 13.1.3.3 Recent developments
    - 13.1.3.3.1 Product launches
    - 13.1.3.3.2 Deals
  - 13.1.3.4 MnM view
    - 13.1.3.4.1 Right to win
    - 13.1.3.4.2 Strategic choices
    - 13.1.3.4.3 Weaknesses & competitive threats
- 13.1.4 WEST PHARMACEUTICAL SERVICES
  - 13.1.4.1 Business overview
  - 13.1.4.2 Products/Solutions/Services offered
  - 13.1.4.3 Recent developments
    - 13.1.4.3.1 Product launches
    - 13.1.4.3.2 Deals
    - 13.1.4.3.3 Expansion
  - 13.1.4.4 MnM view
    - 13.1.4.4.1 Right to win
    - 13.1.4.4.2 Strategic choices
    - 13.1.4.4.3 Weaknesses & competitive threats
- 13.1.5 STEVANATO GROUP
  - 13.1.5.1 Business overview
  - 13.1.5.2 Products/Solutions/Services offered
  - 13.1.5.3 Recent developments
    - 13.1.5.3.1 Product launches
    - 13.1.5.3.2 Deals
    - 13.1.5.3.3 Expansion
  - 13.1.5.4 MnM view
    - 13.1.5.4.1 Right to win
    - 13.1.5.4.2 Strategic choices
    - 13.1.5.4.3 Weaknesses & competitive threats
- 13.1.6 GERRESHEIMER AG
  - 13.1.6.1 Business overview
  - 13.1.6.2 Products/Solutions/Services offered
  - 13.1.6.3 Recent developments
    - 13.1.6.3.1 Product launches
    - 13.1.6.3.2 Deals
    - 13.1.6.3.3 Expansion
  - 13.1.6.4 MnM view
- 13.1.7 SCHOTT
  - 13.1.7.1 Business overview
  - 13.1.7.2 Products/Solutions/Services offered
  - 13.1.7.3 Recent developments
    - 13.1.7.3.1 Product launches
    - 13.1.7.3.2 Deals
    - 13.1.7.3.3 Expansion
  - 13.1.7.4 MnM view
- 13.1.8 NIPRO
  - 13.1.8.1 Business overview
  - 13.1.8.2 Products/Solutions/Services offered
  - 13.1.8.3 Recent developments
    - 13.1.8.3.1 Product launches
  - 13.1.8.4 MnM view
- 13.1.9 CONSTANTIA FLEXIBLES
  - 13.1.9.1 Business overview
  - 13.1.9.2 Products/Solutions/Services offered
  - 13.1.9.3 Recent developments
    - 13.1.9.3.1 Deals
    - 13.1.9.3.2 Expansion
  - 13.1.9.4 MnM view
- 13.1.10 KLOCKNER PENTAPLAST
  - 13.1.10.1 Business overview
  - 13.1.10.2 Products/Solutions/Services offered
  - 13.1.10.3 Recent developments
    - 13.1.10.3.1 Expansion
  - 13.1.10.4 MnM view
13.2 OTHER PLAYERS
- 13.2.1 SONIC PACKAGING INDUSTRIES INC.
- 13.2.2 SHARP SERVICES, LLC
- 13.2.3 TEKNI-PLEX, INC.
- 13.2.4 THERMO-PAK CO. INC.
- 13.2.5 APHENA PHARMA SOLUTIONS
- 13.2.6 PACIFIC VIAL MANUFACTURING INC.
- 13.2.7 HEALTH CARE LOGISTICS, INC.
- 13.2.8 ULTRA SEAL CORPORATION
- 13.2.9 SAFECORE HEALTH
- 13.2.10 UNIT PACK
- 13.2.11 JONES HEALTHCARE GROUP
- 13.2.12 ROPACK INC.
- 13.2.13 RX SYSTEMS, INC.
- 13.2.14 JAMES ALEXANDER CORPORATION
- 13.2.15 PHARMACY AUTOMATION SUPPLIES

14 ADJACENT & RELATED MARKETS

14.1 INTRODUCTION
14.2 LIMITATIONS
- 14.2.1 PHARMACEUTICAL PACKAGING MARKET
  - 14.2.1.1 Market definition
  - 14.2.1.2 Pharmaceutical packaging market, by packaging type
  - 14.2.1.3 Pharmaceutical packaging market, by raw material
  - 14.2.1.4 Pharmaceutical packaging market, by drug delivery
  - 14.2.1.5 Pharmaceutical packaging market, by type
  - 14.2.1.6 Pharmaceutical packaging market, by region
- 14.2.2 NUTRACEUTICAL PACKAGING MARKET
  - 14.2.2.1 Market definition
  - 14.2.2.2 Nutraceutical packaging market, by product form
  - 14.2.2.3 Nutraceutical packaging market, by product type
  - 14.2.2.4 Nutraceutical packaging market, by packaging type
  - 14.2.2.5 Nutraceutical packaging market, by material
  - 14.2.2.6 Nutraceutical packaging market, by ingredient
  - 14.2.2.7 Nutraceutical packaging market, by region

15 APPENDIX

15.1 DISCUSSION GUIDE
15.2 CUSTOMIZATION OPTIONS
15.3 RELATED REPORTS
15.4 AUTHOR DETAILS